×
About 4,455 results

ALLMedicine™ Atrial Flutter Center

Research & Reviews  1,198 results

Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis...
https://doi.org/10.1016/j.jdiacomp.2022.108227
Journal of Diabetes and Its Complications; Handelsman Y, Bunch TJ et. al.

Jun 19th, 2022 - This post hoc analysis evaluated efficacy and safety of dronedarone in atrial fibrillation (AF) and atrial flutter (AFL) patients with/without diabetes. Patients were categorized according to baseline diabetes status. Time-to-event analyses were p...

Full Early Atrial Diagnostics in Single Chamber ICD Patients Using the DX Lead and Home Monitoring in Brazil.
https://clinicaltrials.gov/ct2/show/NCT04869527

Jun 16th, 2022 - To demonstrate the value and benefits of BIOTRONIK's exclusive DX technology in assessing the incidence of supraventricular arrhythmias, mainly atrial fibrillation (AF), in patients with an indication for single chamber ICDs. Effects of the DX tec...

Personalized Persistent Atrial Fibrillation Ablation: The PeAF-by-LAWT Trial
https://clinicaltrials.gov/ct2/show/NCT05396534

Jun 16th, 2022 - Pulmonary vein isolation (PVI) remains the cornerstone of all catheter-based treatment strategies in atrial fibrillation (AF). Currently, PVI is recommended (class IA indication) after one failed or intolerant class I or III antiarrhythmic drug (A...

THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study
https://clinicaltrials.gov/ct2/show/NCT03963349

Jun 14th, 2022 - The purpose of this study is to measure the long term effectiveness,clinical benefit, and safety outcomes of catheter ablation with STSF and AI for paroxysmal atrial fibrillation (PAF) subjects up to 12-month follow-up. Subject:Up to 150 PAF subj...

Cardioversion of Post-Ablation Atrial Tachyarrhythmia with Ibutilide and Amiodarone: A ...
https://doi.org/10.3390/ijerph19116606
International Journal of Environmental Research and Publi... Cacioppo F, Schwameis M et. al.

Jun 11th, 2022 - Patients with recurrence of atrial tachyarrhythmia after catheter ablation for atrial fibrillation or atrial flutter constitute a rapidly growing cohort, but study-driven treatment recommendations are lacking. The present study aimed to compare th...

see more →

Guidelines  3 results

2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults Wi...
https://doi.org/10.1016/j.jacc.2020.08.037
Journal of the American College of Cardiology; Heidenreich PA, Estes NAM et. al.

Dec 12th, 2020 - 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.|2020|Hei...

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stro...
https://doi.org/10.1016/j.cjca.2010.11.007
The Canadian Journal of Cardiology; Cairns JA, Connolly S et. al.

Feb 19th, 2011 - The stroke rate in atrial fibrillation is 4.5% per year, with death or permanent disability in over half. The risk of stroke varies from under 1% to over 20% per year, related to the risk factors of congestive heart failure, hypertension, age, dia...

ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalv...
https://doi.org/10.1161/CIRCULATIONAHA.107.187192
Circulation Estes NA, Halperin JL et. al.

Feb 20th, 2008 - ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the...

see more →

Drugs  201 results see all →

Clinicaltrials.gov  178 results

Full Early Atrial Diagnostics in Single Chamber ICD Patients Using the DX Lead and Home Monitoring in Brazil.
https://clinicaltrials.gov/ct2/show/NCT04869527

Jun 16th, 2022 - To demonstrate the value and benefits of BIOTRONIK's exclusive DX technology in assessing the incidence of supraventricular arrhythmias, mainly atrial fibrillation (AF), in patients with an indication for single chamber ICDs. Effects of the DX tec...

Personalized Persistent Atrial Fibrillation Ablation: The PeAF-by-LAWT Trial
https://clinicaltrials.gov/ct2/show/NCT05396534

Jun 16th, 2022 - Pulmonary vein isolation (PVI) remains the cornerstone of all catheter-based treatment strategies in atrial fibrillation (AF). Currently, PVI is recommended (class IA indication) after one failed or intolerant class I or III antiarrhythmic drug (A...

THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study
https://clinicaltrials.gov/ct2/show/NCT03963349

Jun 14th, 2022 - The purpose of this study is to measure the long term effectiveness,clinical benefit, and safety outcomes of catheter ablation with STSF and AI for paroxysmal atrial fibrillation (PAF) subjects up to 12-month follow-up. Subject:Up to 150 PAF subj...

Tolerance of Centrifuge-induced Acceleration in Subjects With Diabetes Mellitus and Cardiac Arrhythmia
https://clinicaltrials.gov/ct2/show/NCT05404789

Jun 3rd, 2022 - UTMB has received grant funding from the Federal Aviation Administration (FAA) under the Center of Excellence for Commercial Space Transportation to investigate these topics. The concern is whether spaceflight, an already hazardous endeavor, would...

Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant
https://clinicaltrials.gov/ct2/show/NCT04118530

Jun 2nd, 2022 - We propose a registry study in hematopoietic stem cell transplant (HSCT) patients with incident atrial fibrillation/atrial flutter (AF/AFL) during the initial 30 days of transplant who will be implanted with the Medtronic Reveal Linq Implantable C...

see more →

News  198 results

Early Hospital Discharge Following PCI for Patients With STEMI
https://www.mdedge.com/jcomjournal/article/252962/cardiology/early-hospital-discharge-following-pci-patients-stemi
Thai Nguyen, MD, Albert Chan, MD et. al.

Mar 21st, 2022 - Study Overview Objective: To assess the safety and efficacy of early hospital discharge (EHD) for selected low-risk patients with ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PCI). Design: Si.

Ibrutinib Therapy for CLL: Long-Term Data
https://www.onclive.com/view/ibrutinib-therapy-for-cll-long-term-data

Jan 20th, 2022 - William Wierda, MD, PhD: Let’s start with the updates that we’ve had available over the last year. Jackie, we can start with you and if you could sort of give us your thoughts and comments around recent updates over the last data about ibrutinib [...

Rapid Readouts: Ibrutinib Plus Rituximab and Venetoclax Followed by Risk-Stratified Chemoimmunotherapy in Young Patients With Previously Untreated MCL
https://www.onclive.com/view/ibrutinib-plus-rituximab-and-venetoclax-followed-by-risk-stratified-chemoimmunotherapy

Jan 3rd, 2022 - Preetesh Jain, MD, PhD, discusses data from the following study: Ibrutinib plus rituximab and venetoclax followed by risk-stratified observation or short-course R-hyper-CVAD [rituximab, cyclophosphamide, vincristine, doxorubicin hydrochloride, de...

No advantage shown for LAA ligation as adjunct to pulmonary vein isolation
https://www.mdedge.com/cardiology/article/248647/arrhythmias-ep/no-advantage-shown-laa-ligation-adjunct-pulmonary-vein
Ted Bosworth

Nov 15th, 2021 - In patients treated for persistent atrial fibrillation (AFib) with pulmonary vein antral isolation (PVAI), there was a numerical but not a statistical advantage for adjunctive left atrial appendage (LAA) ligation in a multicenter randomized trial.

Enoxaparin-Induced Hemorrhagic Bullae at Sites of Trauma and Endothelial Pathology
https://www.mdedge.com/dermatology/article/247860/wounds/enoxaparin-induced-hemorrhagic-bullae-sites-trauma-and-endothelial
Michael L. Garner, MD, Laura G. Pruitt, MD et. al.

Oct 25th, 2021 - To the Editor: A 67-year-old man with diabetes mellitus was admitted to the hospital for exacerbation of congestive heart failure and atrial flutter with rapid ventricular response. He subsequently developed a non-ST segment elevation myocardial i.

see more →

Patient Education  4 results see all →